Keywordsnon-coding RNAs; micro RNAs; long non-coding RNAs; dyslipidaemia; colorectal cancer; lncRNA; cancer; molecular tumor pathogenesis; microRNAs; genomic instability; cancer; miRNAs; cervical intraepithelial neoplasia (CIN); cervical cancer; miRNA; cardiac development; cardiovascular diseases; hypertrophy; fibrosis; arrhythmia; cardiac regeneration; stem cells; MicroRNAs; bile duct cancer; photodynamic therapy; cytotoxicity; sensitivity; small non-coding RNA; microRNA; microRNA–mRNA interaction; direct microRNA target; microRNA target identification; direct microRNA target validation; long noncoding RNA; hepatocellular carcinoma; dysregulation; biological roles; molecular mechanism; central nervous system (CNS) embryonal tumors; medulloblastoma; atypical teratoid/rhabdoid tumors; microRNAs (miRNAs); biomarkers; telomerase reverse transcriptase; microRNA; RNA-dependent RNA polymerase; cancer; functional genomics; genetically engineered mouse models (GEMM); long intergenic RNA (lincRNA); metastasis; metastasis-associated lung adenocarcinoma transcript 1 (MALAT1); HOX transcript antisense RNA (HOTAIR); microRNA sequencing; mammary gland; swine; microRNA; piwi-interacting RNA; non-coding RNAs; kernel machine; classification; regulatory RNA; antisense transcription; long non-coding RNAs; gene regulation; microRNAs; molecular imaging; spatiotemporal regulation; RILES (RNAi-inducing Luciferase expression system); lncRNAs; functional genomics; transcriptional regulation; post-transcriptional regulation; epigenetics; lncRNAs in plants; resistance training; cardiovascular; microRNA; cardiomyocytes; miR-124a; metabolism; lipolysis; ATGL; CGI-58; miRNA; fiber type; pig; myogenesis; energy metabolism; mir-205; bone mesenchymal stem cells (BMSCs); special AT-rich sequence-binding protein 2 (SATB2); runt-related transcription factor 2 (Runx2); osteogenic differentiation; mitogen activated protein kinase (MAPK); clusters; families of miRNAs; cell signaling pathways; cervical cancer; microRNA; regulation of gene expression; pediatric; sarcoma; miRNA-199a; miRNA-497; DLBCL; prognosis; chemosensitivity; long non-coding RNA; lincRNA-p21; gene regulation; diseases; non-coding RNAs; colorectal cancer; dysregulation; biomarkers; targets; renal cell carcinoma; microRNA; blood serum; biomarker; microRNA; synonymous SNP; functionality; chromatin; epigenetic regulation; gene regulation; heart disease; non-coding RNAs; breast cancer; tamoxifen; endocrine resistance; microRNA; biomarker; long non-coding RNAs; endometrial carcinoma; cancer; benzene; miRNA; hematopoietic progenitor cells; colorectal cancer; miRNA; pathophysiology; diagnosis; prognosis; treatment; non-coding RNA; micro RNAs; long non-coding RNAs; castration-resistant prostate cancer; androgen receptor; cancer metabolism; cerebrospinal fluid; CNS cancers; microRNA; biomarkers; small noncoding RNAs; regulatory RNAs; virulence control mechanism; Gram (+) pathogens; CU interaction motifs; two-component regulators; riboswitches; quorum sensing; toxin/antitoxin systems; miRNA expression; mRNA expression; mi-/mRNA regulatory network; elastic net regression; local enrichment analysis; head and neck squamous cell carcinoma; RNAi; MD; enzyme kinetics; pre-steady-state kinetics; fluorescence spectroscopy; microRNA; gene regulation; cell lines; Ago-2 (Argonaute-2); lncRNAs; function; structure prediction; secondary structure; tertiary structure; miR-16; miR-16-5p; microRNA; endogenous control; housekeeper; control; breast cancer; cancer; chromatin; epigenetic regulation; gene regulation; heart disease; non-coding RNAs; epigenetics; long noncoding RNA; ocular disease; microRNA-155; IFN-γ; C/EBPβ; antibacteria; mycobacterium; renal cell cancer-carcinoma; long non-coding RNAs; metastases; n/a; breast cancer; mmu-miR-1894-3p; tripartite motif containing 46; metastasis; migration; miR-155; H. Pylori; inflammatory bowel disease; colorectal cancer; long non-coding RNA; molecular mechanisms; structure; function; technologies; miR-218; cardiomyocyte; hypertrophy; REST; hepatic fibrosis; inflammation; toll like receptor 4; microRNA-146a; SMA; early motor neuron; miRNA; hiPSCs; coal workers’ pneumoconiosis (CWP); long noncoding RNA; lncRNA-ATB; epithelial-mesenchymal transition (EMT); biomarker; microRNA-381; chondrocyte hypertrophy; histone deacetylase 4; Runt-related transcription factor 2; matrix metalloproteinase 13; long non-coding RNA; lncRNA ZEB1-AS1; glioma; prognostic biomarker; epithelial-mesenchymal transition; cerebral ischemic injury; ischemic stroke; miRNA-378; apoptosis; caspase-3; breast cancer—carcinoma; long non-coding RNA; oncogene; tumor suppressor; n/a; long noncoding RNA; cancer stem cells; liver cancer; tumorigenesis; CAMTA1; miR122; miR33a/b*; nonalcoholic fatty liver disease; obesity; microRNA-375; Recepteur d’Origine Nantais; gastric cancer; miRNAs; diabetes; β-cell function; insulin resistance; circulating miRNAs; miRNA; survival; expression; colorectal; metastasis; metastases; miR-155; allergic disease; asthma; immune response; glucocorticoid; miR-25; DKK3; melanoma; rheumatoid arthritis; miRNA; gender; X-chromosome; FoxP3; microRNA; gene regulation; platelet glycoprotein Ibα; nasopharyngeal carcinoma; metastasis; long non-coding RNA; microarray; maternal-offspring crosstalk; microRNA; noninvasive biomarkers; breast milk; colorectal cancer; sorafenib; miRNA; cementoblast; tensile stress; miRNA; microarray; miR-146b-5p; Smad4; biliary tract cancer; epithelial to mesenchymal transition; microRNA-200 family; microRNA-205; acute myeloid leukemia; risk stratification; chemoresistance; micro-RNA; long non-coding RNA; miR-34a-5p; nuclear receptor subfamily 4, group A, member 2 (NR4A2); lymphoid enhancer-binding factor 1 (LEF1); MYB; hematopoetic progenitor cells; hematopoietic differentiation; megakaryopoiesis; primary myelofibrosis; myeloproliferative neoplasms; macrophage; bladder cancer; c-Myc/PTBP1/PKMs axis; combination RNA-interference treatment; miR-145; Warburg effect; lncRNA; RHPN1-AS1; uveal melanoma; migration; apoptosis; follicular atresia; granulosa cells; microRNA; long non-coding RNAs; prostate cancer; carcinogenesis; tumor-derived exosomes; non-coding RNAs; intercellular communication; biomarkers; exosome-based therapeutics; non-coding RNA; microRNA; long non-coding RNA; circular RNA; cardiac remodeling; microRNAs; next-generation sequencing; cDNA library preparation; formalin-fixed paraffin-embedded; ductal carcinoma in situ; invasive breast cancer; lncRNA; skin cancer; long noncoding RNA; sarcoma; metastasis; prognosis; spinal cord injury; lncRNA-XIST; miR-494; ceRNA; PTEN/PI3K/AKT; colorectal cancer; miRNA; epithelial-mesenchymal transition (EMT); cancer stem cells; metastasis; transposable element; retrotransposon; PIWI; piRNA; endo-siRNA; genome stability; Drosophila; miR-365; glucocorticoid; osteoporosis; histone deacetylase 4; eosinophilic colitis; microRNA; haematochezia; FMRP/dFmr1; fragile-X syndrome; piRNA pathway; crystal-Stellate system; dFmr1 interactors; Hodgkin lymphoma; non-coding RNAs; miRNAs; lncRNAs; piRNAs; miR-365; cutaneous squamous cell carcinoma; BAX; apoptosis; phytochemicals; cancer; apoptosis; coding and non-coding RNA; miRNAs; breast cancer; miRNAs; response to systemic therapy; melanoma; long noncoding RNA; ANRIL; circular RNA; isoforms; CDKN2A/B; placenta; lncRNA; long non-coding RNA; lincRNA; pregnancy; ncRNA; preeclampsia; miR-3648; endoplasmic reticulum stress; Adenomatous polyposis coli 2; proliferation; Wnt; miR-346; miR-582-3p; preeclampsia; preterm delivery; intrauterine growth restriction; epithelial-to-mesenchymal transition; microRNA; tight junction; transcriptome; upper tract urothelial carcinoma; soft tissue sarcoma; microRNAs; tumourigenesis; Wnt; long non-coding RNA; CCAT1; CCAT2; PVT1; H19; lncRNA; H19; breast cancer; non-coding RNA; miRNA; melanoma; tumor microenvironment; epithelial to mesenchymal transition (EMT); immune system; hypoxia; metabolism; miRNA-21; electrochemical sensor; anti DNA–RNA hybrid antibody; ProtA-PolyHRP40; cancer cells; breast human tissues; cancer; epitranscriptomics; lncRNA; noncoding RNA; 5-methylcytosine; m5C; N6-methyladenosine; m6A; pseudouridine; renal cell carcinoma; Von Hippel-Lindau; angiogenesis; microRNAs; lncRNAs; HBV; HBx; HCC; proliferation; epithelial-mesenchymal transition; invasion and metastasis; apoptosis; autophagy; microRNAs; miR-210; BCL11A; hemoglobin; erythroid differentiation; β-thalassemia; γ-globin; non-coding RNA; lncRNA; metabolic organs; liver; pancreas; skeletal muscle; cardiac muscle; adipose tissue; metabolism; energy homeostasis; parkinson’s disease; microRNAs; biomarkers; exosomes; neuroprotective therapies; microRNA (miRNA); integrated analysis; gastric cancer; expression profiling; non-coding RNA; lncRNA; natural antisense transcript; natural antisense transcripts; breast cancer; next generation sequencing; gene expression regulation; microRNA; myogenesis; muscle atrophy; exercise; sport injury; non-coding RNA; plant diseases; genetic control; immunity; defense response; miRNAs; fluoxetine; antidepressant; depression; hippocampus; microRNA; PKM; PKLR; PTBP1; Warburg effect; n/a; novel microRNA; N-72; EGF; cell migration; hAMSC; MMP2; long non-coding RNA; Malat1; angiogenesis; vascular endothelial cells; VEGFR2; hindlimb ischemia; lncRNA; ITGB2-AS1; ITGB2; breast cancer; migration; invasion; m6A; m6A writer; m6A eraser; m6A reader; cancer development; glioma; glioblastoma; long non-coding RNA; biomarker; diagnosis; prognosis; molecular pathology; ototoxicity; microRNA; hearing loss; serum; giant panda; lncRNA; mRNA; frozen-thawed sperm; transcriptome sequencing; microRNAs; diagnosis; testicular cancer; miR-34 family; guide strand; passenger strand; cell processes; long non-coding RNAs; NEAT1; paraspeckles; viral diseases; neurodegeneration; MG; chicken; PI3K/Akt/NF-κB pathway; gga-miR-16-5p; microRNA; cardiac protection; apoptosis; Let-7d-3p; HMGA2; miRNA; biomarker; opioid; cancer pain; hydromorphone; senescence; lncRNAs; signaling pathways; cancer; aging; circRNAs; backsplice sequence; divergent primers; RNase R; RT-PCR; alternative splicing; splice variants; microRNAs; breast cancer; oncomiR; tsmiR; lncRNA; epigenetic; transcriptional; post-transcriptional; translation; post-translational modification; ncRNA; miRNAs; lncRNAs; circRNAs; ESCC; human adipose-derived mesenchymal stem/stromal cells; adipose-derived stem cells; mesenchymal stem cells; microRNAs; paracrine effect; immunomagnetic bead sorting; stromal vascular fraction; insulin resistance; hepatic; liver; miRNA; lncRNA; ncRNA; circulating; marker; noncoding RNA; double-strand breaks (DSBs), DNA repair; DNA damage response (DDR); myocardial ischemia; long noncoding RNA; RNA sequencing; NUMB; isoforms; cell migration; Notch1; SMAD3; microRNA449a; triple negative breast cancer; DNA repair; chromosomal instability; chromatid separation; microRNAs; miRNAs; rheumatoid arthritis; RA; cardiovascular complications; CVD; atherosclerosis; pericarditis; myocardial infarction; TRUE gene silencing; sgRNA; tRNase ZL; RNA therapeutics; multiple myeloma; tumor-associated macrophage; miRNA; uterine cervix; squamous cell carcinoma; metastasis; miR-30e-5p; miR-22-3p; histone modifications; non-coding RNAs; epigenetics; biomarker; miRNA; miRNA target; chronic primary pain; chronic secondary pain; pain pathogenesis; cervical cancer; cervical intraepithelial neoplasia; long noncoding RNAs; microRNA; long noncoding RNA; gene expression; chromatin; CRISPR-Cas9; microRNA; prostate cancer (PC); diagnosis; miRNA secretion; exosomes; microvesicles; Drosophila; leg imaginal disc; lncRNA; development; scRNA-seq; scATAC-seq; circular RNA (circRNA); microRNA (miRNA); isomiR; cancer metastasis; competing endogenous RNA (ceRNA) network; microRNA; cell type specificity; miRNA expression profiles; chromatin activity; miRNA–disease association; long noncoding RNA; brown fat; ectopic fat; beige fat; adipose tissue; cortisol; ACTH; miRNA; Cushing’s; hypercortisolism; pituitary; ovarian cancer; cisplatin resistance; RNA-seq; bioinformatics; long noncoding RNAs; microRNA; inflammation; monocyte trafficking; adhesion; chemotaxis; microRNA; miR-140; aging-related diseases; non-coding RNA; disease association; network mining; deep learning; mode of action; integrative analysis; enhancer RNA; eRNA; cancer; neurodegenerative disorder; cardiovascular disease; metabolic disease; transcriptional regulation; gene expression; regulation; barley; miRNAs; plants; environmental stress; insulin resistance; long non-coding RNA; metabolic diseases; microRNAs; noninvasive biomarkers; liver transplant; follow-up timing; miR-150; G-quadruplex; microRNA; zebrafish; embryonic development; intestinal microbiota; microRNA; dysbiosis; ulcerative colitis; Crohn’s disease; inflammatory bowel; influenza A virus; long noncoding RNA; interferon; viral replication; innate immunity; long noncoding RNA; osteocyte; bone formation; microgravity; non-coding RNAs; salidroside; cellular senescence; BK-dependent apoptosis
